PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions

Volume: 60, Issue: 1, Pages: 262 - 264
Published: Jun 22, 2018
Abstract
Treatment with tyrosine kinase inhibitors (TKIs) results in remission and prolongation of survival, but fails to eliminate the leukemia stem cells (LSCs) responsible for disease development and...
Paper Details
Title
PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions
Published Date
Jun 22, 2018
Volume
60
Issue
1
Pages
262 - 264
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.